Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers
- PMID: 28883969
- PMCID: PMC5530928
- DOI: 10.1186/s40794-016-0042-9
Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers
Abstract
The HIV pandemic persists globally and travelers are at risk for infection by the Human Immunodeficiency Virus (HIV). While HIV-focused guidelines delineate risk stratification and mitigation strategies for people in their home communities, travel issues are not addressed. In this review, direct and indirect evidence on HIV risk among travelers is explored. The burgeoning practice of employing pre-exposure prophylaxis (PrEP) with anti-retroviral therapy in the non-travel setting is introduced, as well as the more established use of post-exposure prophylaxis (PEP). Challenges in applying these lessons to travelers are discussed, and a new guidelines process is scoped and recommended.
Keywords: Human Immunodeficiency Virus; Post-exposure; Pre-exposure; Prophylaxis; Review; Travel.
Figures
References
-
- World Health Organization . Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015. - PubMed
-
- US Public Health Service . Preexposure prophylaxis for the prevention of HIV infection in the United States- 2014: A clinical practice guideline. Atlanta: Centers for Disease Control and Prevention; 2014.
-
- U.S. Travel Association. 2016. https://www.ustravel.org/answersheet. Accessed 26 July 2016.
-
- National Travel and Tourism Office. U.S. Outbound Travel by World Regions. 2015. http://travel.trade.gov/view/m-2015-O-001/index.html. Accessed 26 July 2016.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
